Abstract
In the report by Kenny-Walsh and the Irish Hepatology Research Group (April 22 issue)1 on the outbreak of hepatitis C in Ireland in 1977 associated with the administration of anti-D immune globulin contaminated with hepatitis C virus (HCV), Table 1 lists the estimated number of recipients of anti-D immune globulin on the basis of the estimated number of vials issued and the number of recipients tested. We would like to supply more precise details.